TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference Feb 25, 2026 07:00AM
TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference Feb 27, 2025 07:00AM
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares Apr 24, 2024 11:03AM
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares Apr 24, 2024 11:03AM
TScan Therapeutics Announces Closing of Upsized Public Offering Apr 19, 2024 10:05AM


Apr 17, 2024 11:35AM TD Cowen analsyt comments on TScan Therapeutics (TCRX) following update on solid tumor and heme malignancies clinical programs
Apr 17, 2024 12:45AM TScan Therapeutics, Inc (TCRX) Announces Pricing of Upsized $150 Million Public Offering
Apr 17, 2024 12:30AM TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
Apr 16, 2024 04:26PM TScan Therapeutics (TCRX) Launches $125 Million Proposed Public Offering of Common Stock, Warrants
Apr 16, 2024 04:25PM TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
Feb 28, 2024 07:00AM TScan Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
Mar 1, 2023 07:00AM TScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
Mar 1, 2023 07:00AM TScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference
Mar 2, 2022 07:00AM TScan Therapeutics to Participate in Upcoming Investor Conferences
Aug 13, 2021 05:33AM Cowen Starts Tscan Therapeutics Inc (TCRX) at Outperform
Jul 16, 2021 11:38AM TScan Therapeutics, Inc (TCRX) IPO Opens 20% Lower
Jul 16, 2021 05:00AM TScan Therapeutics, Inc (TCRX) Price 6.7M Share IPO at $15/sh
Jul 15, 2021 06:59PM TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering